These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2880069)

  • 1. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man.
    Chung KF; Dent G; McCusker M; Guinot P; Page CP; Barnes PJ
    Lancet; 1987 Jan; 1(8527):248-51. PubMed ID: 2880069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man.
    Hayes JP; Ridge SM; Griffith S; Barnes PJ; Chung KF
    J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a PAF-antagonist (BN 52063) on bronchoconstriction and platelet activation during exercise induced asthma.
    Wilkens JH; Wilkens H; Uffmann J; Bövers J; Fabel H; Frölich JC
    Br J Clin Pharmacol; 1990 Jan; 29(1):85-91. PubMed ID: 2297463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of BN 52063 on PAF-acether induced weal and flare in man.
    Guinot P; Braquet P; Duchier J; Cournot A
    Agents Actions Suppl; 1987; 21():239-43. PubMed ID: 3479000
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist.
    Guinot P; Braquet P; Duchier J; Cournot A
    Prostaglandins; 1986 Jul; 32(1):160-3. PubMed ID: 3763944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activating factor-induced clinical and histopathologic responses in atopic skin and their modification by the platelet activating factor antagonist BN52063.
    Markey AC; Barker JN; Archer CB; Guinot P; Lee TH; MacDonald DM
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):263-8. PubMed ID: 2212123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
    Földes-Filep E; Braquet P; Filep J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjects.
    Roberts NM; Page CP; Chung KF; Barnes PJ
    J Allergy Clin Immunol; 1988 Aug; 82(2):236-41. PubMed ID: 3403863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
    Braquet P
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.
    Mandi Y; Farkas G; Koltai M; Beladi I; Mencia-Huerta JM; Braquet P
    Immunology; 1989 Jul; 67(3):370-4. PubMed ID: 2759659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of PAF-induced platelet aggregation in man.
    Küster LJ; Filep J; Frölich JC
    Thromb Res; 1986 Aug; 43(4):425-33. PubMed ID: 3764802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of the platelet-activating factor antagonist BN 52063 on exertional asthma].
    Wilkens H; Wilkens JH; Uffmann J; Bövers J; Fröhlich JC; Fabel H
    Pneumologie; 1990 Feb; 44 Suppl 1():347-8. PubMed ID: 2142294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial.
    Gavriil L; Detopoulou M; Petsini F; Antonopoulou S; Fragopoulou E
    Br J Nutr; 2019 May; 121(9):982-991. PubMed ID: 30940217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
    Schattner M; Parini A; Fouque F; Vargaftig BB; Touqui L
    Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man.
    Chung KF; Minette P; McCusker M; Barnes PJ
    J Allergy Clin Immunol; 1988 Jun; 81(6):1192-8. PubMed ID: 3288683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine potentiates human platelet aggregation induced by platelet-activating factor.
    Sipka S; Koltai M; Braquet P; Szegedi G
    Int Arch Allergy Immunol; 1992; 97(1):89-92. PubMed ID: 1582704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of ginkgolide A, B and K on platelet aggregation].
    Wang KL; Li ZQ; Cao ZY; Ke ZP; Cao L; Wang ZZ; Xiao W
    Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4722-4726. PubMed ID: 29493137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.